Biopure Falls

PDI inks pact with Novartis; McDonalds says it has no connection to Mad Cow situation; plus more of today's stocks to watch

Biopure (BPUR ) shares fell after the company says the Securities and Exchange Commission is considering a civil injunctive proceeding against it relating to its disclosures concerning its communications with the Food and Drug Administration about a trauma study protocol submitted in March 2003 that's related to its clinical trial for Hemopure, an oxygen-carrying product that Biopure is developing that may be used as an alternative to red-blood-cell transfusions and for other uses.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.